Grufity logoGrufity logo

CNO Financial Group Inc Stock Research

CNO

21.12USD+0.16(+0.76%)Delayed

Market Summary

USD21.12+0.16
Delayed
0.76%

CNO Alerts

CNO Stock Price

CNO RSI Chart

CNO Valuation

Market Cap

2.4B

Price/Earnings (Trailing)

6.09

Price/Sales (Trailing)

0.68

EV/EBITDA

1.77

Price/Free Cashflow

4.87

CNO Price/Sales (Trailing)

CNO Profitability

EBT Margin

14.46%

Return on Equity

28.33%

Return on Assets

1.19%

Free Cashflow Yield

20.51%

CNO Fundamentals

CNO Revenue

Revenue (TTM)

3.6B

Revenue Y/Y

-9.42%

Revenue Q/Q

7.54%

CNO Earnings

Earnings (TTM)

396.8M

Earnings Y/Y

-62.52%

Earnings Q/Q

-58.67%

Price Action

52 Week Range

16.5626.35
(Low)(High)

Last 7 days

-2.7%

Last 30 days

-15.6%

Last 90 days

-7.6%

Trailing 12 Months

-15.7%

CNO Financial Health

CNO Investor Care

Dividend Yield

2.47%

Dividend/Share (TTM)

0.48

Buy Backs (1Y)

5.01%

Diluted EPS (TTM)

3.37

Peers (Alternatives to CNO Financial Group)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
82.1B
49.6B
-1.45% 23.08%
113.76
1.65
4.00% -78.47%
42.3B
69.9B
-23.30% -20.83%
16.68
0.61
-1.66% -61.26%
39.6B
19.5B
-8.02% -0.58%
9.42
2.03
-11.78% -2.87%
38.3B
36.9B
-11.40% -9.04%
13.47
1.04
5.94% -22.39%
17.4B
17.5B
-18.79% 0.52%
3.62
1
22.64% 181.28%
MID-CAP
10.0B
16.3B
-13.53% 18.41%
37
0.61
-2.40% 0.97%
7.6B
12.0B
-9.63% 24.94%
5.75
0.63
-0.19% 59.45%
6.0B
10.2B
-13.09% -37.50%
21.54
0.58
0.05% -79.62%
2.4B
3.6B
-15.59% -15.74%
6.09
0.68
-13.23% -10.02%
2.4B
7.5B
-20.83% 27.35%
3.86
0.31
-4.15% -32.63%
1.6B
905.2M
-29.71% -58.57%
-35.21
1.74
29.50% -25.73%
SMALL-CAP
1.4B
1.4B
-10.42% -18.96%
-523.07
0.98
3.97% -101.82%
1.3B
327.1M
-8.98% -16.27%
25.76
4.11
39.88% 13.79%
776.0M
813.7M
-6.42% -3.67%
25.05
0.95
5.28% 117.92%

Financials for CNO Financial Group

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-2.8%3,5773,6783,7413,9594,122
EBITDA-10.8%1,0001,1211,069942-
EBITDA Margin-8.3%0.28*0.30*0.50*0.24*-
Earnings Before Taxes-15.2%517610601527568
EBT Margin-12.8%0.14*0.17*0.28*0.13*-
Interest Expenses21.5%13711399.0095.0095.00
Net Income-15.4%397469464406441
Net Income Margin-13.0%0.11*0.13*0.22*0.10*-
Free Cahsflow9.2%495454527565-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets0.9%33,33933,03733,83635,46836,204
    Cash Equivalents16.5%645554619594732
Liabilities0.6%31,93831,73931,62431,77730,945
Shareholder's Equity7.9%1,4011,2982,2123,6915,260
  Retained Earnings1.9%1,4591,4321,3431,2241,127
  Additional Paid-In Capital0.2%2,0342,0312,0332,0862,184
Shares Outstanding0.0%114114115117120
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations9.2%495454527565598
Cashflow From Investing22.5%-1,781-2,298-2,206-2,202-1,526
Cashflow From Financing-24.4%1,1991,5861,5841,492668
  Dividend Payments0.5%65.0065.0065.0066.0066.00
  Buy Backs-32.1%190280385412408

Risks for CNO

What is the probability of a big loss on CNO?

70%


Probability that CNO Financial Group stock will be more than 20% underwater in next one year

52.7%


Probability that CNO Financial Group stock will be more than 30% underwater in next one year.

20.4%


Probability that CNO Financial Group stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CNO drawdown profile look like?

Y-axis is the maximum loss one would have experienced if CNO Financial Group was unfortunately bought at previous high price.

Drawdowns

Returns for CNO

Cumulative Returns on CNO

8.2%


10-Year Cumulative Returns

4.4%


7-Year Cumulative Returns

2.1%


5-Year Cumulative Returns

25.4%


3-Year Cumulative Returns

What are the long-term rolling returns for CNO?

FIve years rolling returns for CNO Financial Group.

Annualized Returns

Which funds bought or sold CNO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
110
1,156,940
1,846,940
-%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-47.21
-7,000
12,000
-%
2023-02-28
Voya Investment Management LLC
reduced
-4.17
605,013
3,375,010
-%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
98,000
464,000
-%
2023-02-21
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC
reduced
-35.92
-55,064
241,936
0.01%
2023-02-21
MACQUARIE GROUP LTD
reduced
-2.00
592,000
3,295,000
-%
2023-02-17
TRUIST FINANCIAL CORP
new
-
932,636
932,636
-%
2023-02-16
MAVERICK CAPITAL LTD
added
26.2
118,045
313,045
0.01%
2023-02-15
MetLife Investment Management, LLC
reduced
-1.11
605,344
2,958,340
0.02%
2023-02-15
HOWE & RUSLING INC
sold off
-100
-4,000
-
-%

1–10 of 50

Latest Funds Activity

Are funds buying CNO calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CNO
No. of Funds

CNO Financial Group News

PR Newswire

CNO Financial Group Donates to 17 Nonprofits Through its Annual ....

PR Newswire,
3 days ago

Investor's Business Daily

Zacks Investment Research

Zacks Investment Research

Schedule 13G FIlings of CNO Financial Group

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
fuller & thaler asset management, inc.
6.37%
7,289,612
SC 13G/A
Feb 09, 2023
blackrock inc.
13.3%
15,179,705
SC 13G/A
Feb 09, 2023
vanguard group inc
12.13%
13,871,812
SC 13G/A
Jan 26, 2023
blackrock inc.
13.3%
15,179,705
SC 13G/A
Jan 23, 2023
pzena investment management llc
6.66%
7,627,617
SC 13G/A
Jan 20, 2023
blackrock inc.
13.3%
15,179,705
SC 13G/A
Feb 09, 2022
vanguard group inc
11.08%
13,660,551
SC 13G/A
Feb 08, 2022
fuller & thaler asset management, inc.
5.68%
6,999,775
SC 13G
Feb 08, 2022
dimensional fund advisors lp
4.8%
5,967,483
SC 13G/A
Jan 31, 2022
blackrock inc.
11.9%
14,614,072
SC 13G/A

CNO Fair Value

CNO Financial Group fair value in different scenarios

The table shows the Fair Value estimates for CNO Financial Group for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

3.90

-81.53%

10.49

-50.33%

19.61

-7.15%

30.28

43.37%
Current Inflation

0.13

-99.38%

2.74

-87.03%

8.77

-58.48%

16.16

-23.48%

25.22

19.41%
Very High Inflation

-

-

1.25

-94.08%

6.58

-68.84%

12.00

-43.18%

19.21

-9.04%

Historical CNO Financial Group Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of CNO Financial Group

View All Filings
Date Filed Form Type Document
Mar 06, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
8-K
Current Report
Feb 24, 2023
10-K
Annual Report
Feb 23, 2023
8-K
Current Report
Feb 21, 2023
4
Insider Trading
Feb 17, 2023
4
Insider Trading
Feb 17, 2023
4/A
Insider Trading
Feb 16, 2023
4
Insider Trading

Latest Insider Trading transactions for CNO

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-06
Zimpfer Matthew J.
sold
-85,516
25.8514
-3,308
evp and general counsel
2023-03-01
Goldberg Scott L.
sold
-59,039
25.6804
-2,299
president, consumer division
2023-02-27
Zimpfer Matthew J.
sold
-109,000
26.0268
-4,188
evp and general counsel
2023-02-21
Zimpfer Matthew J.
sold
-90,865
25.0593
-3,626
evp and general counsel
2023-02-16
Byers Michael B
sold (taxes)
-15,142
25.45
-595
president, worksite
2023-02-14
Zimpfer Matthew J.
acquired
478,159
25.57
18,700
evp and general counsel
2023-02-14
Mead Michael E.
sold (taxes)
-93,867
25.57
-3,671
chief information officer
2023-02-14
TARASI ROCCO F III
sold (taxes)
-185,587
25.57
-7,258
chief marketing officer
2023-02-14
TARASI ROCCO F III
acquired
613,680
25.57
24,000
chief marketing officer
2023-02-14
DeToro Karen
sold (taxes)
-185,408
25.57
-7,251
chief actuary

1–10 of 50

Gary C. Bhojwani
3350
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.

CNO Income Statement

2022-12-31
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:   
Insurance policy income$ 2,499.8$ 2,523.4$ 2,511.3
Net investment income:   
General account assets1,179.01,140.21,079.0
Policyholder and other special-purpose portfolios(163.1)280.5143.5
Investment gains (losses):   
Realized investment gains (losses)(17.9)21.3(18.4)
Other investment gains (losses)(117.5)(2.2)(17.8)
Total investment gains (losses)(135.4)19.1(36.2)
Fee revenue and other income196.5159.0123.5
Total revenues3,576.84,122.23,821.1
Benefits and expenses:   
Insurance policy benefits1,658.32,190.72,157.9
Interest expense137.095.4108.8
Amortization309.6281.1268.1
Other operating costs and expenses954.6987.3942.0
Total benefits and expenses3,059.53,554.53,476.8
Income before income taxes517.3567.7344.3
Income tax expense (benefit):   
Tax expense on period income120.5126.776.5
Valuation allowance for deferred tax assets and other tax items0.00.0(34.0)
Net income$ 396.8$ 441.0$ 301.8
Basic:   
Weighted average shares outstanding (in shares)115,733128,400142,096
Net income (in USD per share)$ 3.43$ 3.43$ 2.12
Diluted:   
Weighted average shares outstanding (in shares)117,717131,126143,164
Net income (in USD per share)$ 3.37$ 3.36$ 2.11

CNO Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Investments:  
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: 2022 - $56.0 and 2021 - $7.6; amortized cost: 2022 - $23,384.2 and 2021 - $21,867.6)$ 20,353.4$ 24,805.4
Equity securities at fair value135.3131.1
Mortgage loans (net of allowance for credit losses: 2022 - $8.0 and 2021 - $5.6)1,411.91,218.6
Policy loans121.6120.2
Trading securities207.9227.2
Investments held by variable interest entities (net of allowance for credit losses: 2022 - $5.5 and 2021 - $3.7; amortized cost: 2022 - $1,134.2 and 2021 - $1,206.8)1,077.61,199.6
Other invested assets1,034.71,224.0
Total investments24,342.428,926.1
Cash and cash equivalents - unrestricted575.7632.1
Cash and cash equivalents held by variable interest entities69.299.6
Accrued investment income235.6216.4
Present value of future profits212.2222.6
Deferred acquisition costs1,913.41,112.0
Reinsurance receivables (net of allowance for credit losses: 2022 - $2.0 and 2021 - $3.0)4,241.74,354.3
Income tax assets, net1,165.5118.3
Assets held in separate accounts2.73.9
Other assets580.8519.1
Total assets33,339.236,204.4
Liabilities for insurance products:  
Policyholder account liabilities14,858.313,689.7
Future policy benefits11,809.111,670.7
Liability for policy and contract claims456.5501.8
Unearned and advanced premiums235.0246.7
Liabilities related to separate accounts2.73.9
Other liabilities693.9830.9
Investment borrowings1,639.51,715.8
Borrowings related to variable interest entities1,104.61,147.9
Notes payable – direct corporate obligations1,138.81,137.3
Total liabilities31,938.430,944.7
Commitments and Contingencies
Shareholders' equity:  
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2022 - 114,343,070 and 2021 - 120,377,152)1.11.2
Additional paid-in capital2,033.82,184.2
Accumulated other comprehensive income(2,093.1)1,947.1
Retained earnings1,459.01,127.2
Total shareholders' equity1,400.85,259.7
Total liabilities and shareholders' equity$ 33,339.2$ 36,204.4